RxDoctor Payments Data

Kevin Via, MD

Family Medicine · Columbia, SCNPI 1215340542

Payments from drug & device makers

$566in general payments, 2019–2025

Across 25 payments — averaging $22.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Dexcom, Inc.$189
  • Lilly USA, LLC$70
  • AbbVie$65
  • AstraZeneca$50
  • Novo Nordisk$45
  • Esperion Therapeutics, Inc.$25
  • plus $123 from 7 others

What the payments were for

  • Food & beverage$566100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$566 in reported general payments places this provider in the 50th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$193,115
Medicare patients
418
Services billed
3,036

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide58$122,185
OzempicSemaglutide73$100,201
EliquisApixaban76$63,953
JanuviaSitagliptin Phosphate58$62,894
JardianceEmpagliflozin47$61,633
RybelsusSemaglutide30$42,151
TrulicityDulaglutide24$41,554
FarxigaDapagliflozin Propanediol23$27,371
XareltoRivaroxaban27$26,896
ViberziEluxadoline12$18,685
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog12$8,455
Lantus SolostarInsulin Glargine,hum.Rec.Anlog37$8,404
Rosuvastatin Calcium287$5,196
Atorvastatin Calcium351$4,479
Wixela InhubFluticasone Propion/Salmeterol15$4,450

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$70$163,73982 claims
Novo NordiskOzempic, Rybelsus$45$142,352103 claims
PfizerEliquis$21$63,95376 claims
MerckJanuvia$19$62,89458 claims
AstraZenecaFarxiga$50$27,37123 claims
AbbVieViberzi$65$18,68512 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Columbia

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →